A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61K 31/505 (2006.01)
Patent
CA 2303752
Methods for treating treatment-naive as well as treatment-experienced patients having RCC to achieve at least a partial tumor response involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g. , pegylated interferon alfa-2b as monotherapy or in association with a therapeutically effective amount of IL-2 are disclosed.
Rose Esther Helen
Rybak Mary Ellen
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Renal cell carcinoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renal cell carcinoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renal cell carcinoma treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1665547